Results
(125 Answers)

Answer Explanations 23

Fill data gaps Quantitative risk assessment
user-995929

They can help to fill data gaps but not for extrapolation.
Quantitative risk assessment is possible strong area where AI, ML can contribute.

Prioritization/screening of candidate agents Fill data gaps Relative potencies Hazard ID/endpoint alerts
user-532952

Not sure I would trust them for quantitative risk assessment unless samples were large enough. and the evidence was good.

Prioritization/screening of candidate agents Relative potencies Read across Quantitative risk assessment
user-377267

As soon as some data (in vitro, QSARs, biomarkers, blood levels etc.) are available, AI and ML can be very helpful. Such cases mainly comprise Dose-response-modeling, benchmark dose identification, uncertainty analysis and kinetic modeling (including body burden considerations)

Prioritization/screening of candidate agents Fill data gaps Hazard ID/endpoint alerts Quantitative risk assessment
user-77300

These may represent future applications

Prioritization/screening of candidate agents Read across Hazard ID/endpoint alerts Quantitative risk assessment
user-901200

Currently the main impediment is the lack of a reliable gold standard to train our models. We are often required to use results from existing in vivo assays as if they were the ultimate gold standard to achieve, when they are very noisy and inconsistent, even when repeating the exact same assay with the same model organism.

Prioritization/screening of candidate agents Read across Other (please explain below)
user-63535

Predicting results of specific studies

Prioritization/screening of candidate agents Fill data gaps Relative potencies Read across Hazard ID/endpoint alerts
user-125195

EPA's tox cast program was developed using such approaches as a means to screen and prioritize the US commercial chemical inventory to identify candidate agents that merit priority consideration and those that can wait. As part of this effort the approaches used hazard id/endpoint alerts, relative potency considerations and read across-like considerations to identify candidates. They have also been used in regulatory agencies and industry to fill data gaps such the reliable prediction of pchem properties for certain well characterized classes of chemicals where such have not been actually measured for certain members of that class

Prioritization/screening of candidate agents Fill data gaps Relative potencies Read across Hazard ID/endpoint alerts Quantitative risk assessment
user-74194

A human or better a small group of humans still needs to evaluate the results.

user-678105

No confidence based on my experience.

user-598239

Again "high confidence" is a high bar. In general parlance, this may be equivalent to proof beyond a reasonable doubt. If so, none at the moment.

If it is preponderance of the evidence, then this is a different level and then maybe initial hazard ID and initial screening.

Prioritization/screening of candidate agents Relative potencies Hazard ID/endpoint alerts Quantitative risk assessment
user-441980

AI & ML will certainly help in the screening of candidate agents to prioritize, to identify susceptive groups, risk prediction.

Prioritization/screening of candidate agents Relative potencies Read across Hazard ID/endpoint alerts
user-571430

Data gaps require more detailed focussed experiments. Quantitative risk assessment requires a dose-response relationship which might be liner or nonlinear, and it is not always predictable.

user-43697

As mentioned, the available models are of no use in toxicology for the time being. Of course, this is no impediment for some to use them anyway, but the old adage "garbage in - garbage out" still applies. The least damage would probably be done by using AI for prioritizing purposes or screening of candidate agents. However, better and somewhat more relevant models (in vitro screening assays, HTS) are already avaliable and well-established and I do not see any immediate need for half-baked computer-based models.

Quantitative risk assessment
user-542826

For QRA based on actual data

user-271773

Too early to guess, and the options considered for AI or ML might also be best themselves addressed with AI. Training is necessary but constraint based on, for example, the 1950's bright line decision approaches we rely on, might waste value or create harm

Prioritization/screening of candidate agents Read across Hazard ID/endpoint alerts Other (please explain below)
user-90122

What computational toxicology, cheminformatics, nanoinformatics, etc already does great is summarize patterns and point is to prominent effects. I recommend reading the literature about AI/ML has been used in the past 20 years in medicinal chemistry, e.g. the articles by Yvonne Martin (https://scholar.google.com/citations?hl=en&user=YKsl2jEAAAAJ).

Prioritization/screening of candidate agents Fill data gaps Hazard ID/endpoint alerts
user-446741

Only non-critical data gaps.

Some level of quantitation is currently achievable for some endpoints allowing use for setting exposure limits for low-exposure compounds for example.

Fill data gaps Relative potencies Read across Quantitative risk assessment
user-918734

Selected seems less problematic. Prioritization will be the most difficult prediction model given the evolution of values.

Prioritization/screening of candidate agents Other (please explain below)
user-320876

statistical analyses.

Prioritization/screening of candidate agents Fill data gaps Relative potencies Read across
user-711942

There will be a need for interpretation and implementation.

Fill data gaps Read across
user-986831

Based

Read across Hazard ID/endpoint alerts
user-480186

Useful but not completely reliable.

Prioritization/screening of candidate agents Read across
user-900365

With the limited data - AI/ML is great in screening and prioritize chemicals for further testings.

Please log in to comment.